A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Study Identifier
CMA-OZU-12-001
CT.gov Identifier
NCT01805323
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • Dexamethasone Intravitreal Implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Retinal disease involving macular edema * Received at least one OZURDEX® injection
    Exclusion Criteria:
    * None

    Protocol Summary

    This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.

    Study Locations

    Location
    Status
    Location
    Québec, Quebec, Canada
    Status
    Not applicable